🇺🇸 FDA
Patent

US 7416878

Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 7416878 (Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/098